Nanovision Technology
PrivateLast Round
Series C
Extension
Nov 30, 2024
Est. Valuation
$4.48B
Total Funding Raised
$190.93M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nanovision Technology is a medical device company that specializes in the research, development, production, and service of high-speed, high-precision radiation imaging solutions, including phased array CT systems, X-ray detectors, and medical imaging software.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanovision Technology Comparables
Compare Nanovision Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai United Imaging Healthcare | 77% | |
| MinFound Medical Systems Co., Ltd. | 77% | |
| NuRay Technology Co., Ltd. | 76% |
Nanovision Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Nov 30, 2024 | ||||
| Private Placement | Jul 12, 2022 | ||||
| Strategic | Mar 23, 2022 | ||||
| Series C | Nov 11, 2021 | ||||
| IPO | Jun 23, 2021 | ||||
Series C Extension | Feb 1, 2020 |
Nanovision Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guotai Junan Securities (Hong Kong) Limited | Private Placement |
| China Galaxy Securities Co., Ltd. | Private Placement |
| SDIC Unity Capital | Series B, Series C |
| Hillhouse Investment | Series B |
| YuanBio Venture Capital | Series B, Series C, Series A |
| Northern Light Venture Capital | Series C |
| Huimei Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
Weitao Li joins as Director of Corporate Communications.
- Jul 12, 2022
$29M raised from Caitong Fund Management, GF Fund, and others.
Nanovision Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nanovision Technology's valuation, stock price, and market status.
Is Nanovision Technology a public or private company?
Nanovision Technology is a private company.
What is the current stock price of Nanovision Technology?
Nanovision Technology is a private company with no public stock price. No recent secondary market data is available.
How much is Nanovision Technology worth (valuation)?
Nanovision Technology's valuation is estimated at $128.5M based on funding round data.
Can I buy Nanovision Technology stock?
Nanovision Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nanovision Technology's last funding round?
Nanovision Technology's most recent funding round was Series C Extension on March 22, 2022.
Who are the main investors in Nanovision Technology?
Key investors in Nanovision Technology include Legend Capital.
Will Nanovision Technology IPO soon?
No public IPO plans have been announced for Nanovision Technology.
How can I track Nanovision Technology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nanovision Technology's secondary market activity and sign up for updates.